Company: SUPN
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0001356576-25-000017
Chunk: 41

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1C
Chunk 41
---
 reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Baltimore, Maryland

February 25, 2025 

91

Supernus Pharmaceuticals, Inc.

Consolidated Balance Sheets

(in thousands, except share and per share data) December 31, 2024December 31, 2023AssetsCurrent assetsCash and cash equivalents$69,331 $75,054 Marketable securities384,281 179,820 Accounts receivable, net142,077 144,155 Inventories, net54,293 77,408 Prepaid expenses and other current assets36,088 16,676 Total current assets686,070 493,113 Long-term marketable securities— 16,617 Property and equipment, net11,545 13,530 Intangible assets, net521,912 599,889 Goodwill117,019 117,019 Other assets31,527 37,505 Total assets$1,368,073 $1,277,673 Liabilities and stockholders’ equityCurrent liabilitiesAccounts payable and accrued liabilities$76,352 $79,569 Accrued product returns and rebates168,705 154,274 Contingent consideration, current portion47,340 52,070 Other current liabilities— 4,283 Total current liabilities292,397